Literature DB >> 28808865

Glucagon-Like Peptides 1 and 2 Are Involved in Satiety Modulation After Modified Biliopancreatic Diversion: Results of a Pilot Study.

Everton Cazzo1, José Carlos Pareja2, Elinton Adami Chaim2, Cláudio Saddy Rodrigues Coy2, Daniéla Oliveira Magro2.   

Abstract

BACKGROUND: This paper aimed to evaluate the influence of modified biliopancreatic diversion (BPD) on the levels of GLP-1 and GLP-2 and correlate them with satiety regulation.
METHODS: This is a pilot prospective cohort study that evaluated six mildly obese individuals with type 2 diabetes mellitus, which underwent modified BPD and were followed-up for 12 months. Levels of GLP-1 and GLP-2 after a standard meal tolerance test were determined and correlated with satiety scores obtained by means of a visual analogue scale (VAS).
RESULTS: There were significant changes in BMI (33 ± 2.2 versus 26.3 ± 2.2 kg/m2; p < 0.001), HbA1c (7.9 ± 1.6 versus 5.8 ± 1.2%; p = 0.026), total cholesterol (172.3 ± 11.1 versus 134.7 ± 16.1 mg/dL; p < 0.001), LDL-c (103.3 ± 13 versus 64.6 ± 12.2 mg/dL; p < 0.001), and postprandial GLP-2 (972.7 ± 326.2 versus 1993.2 ± 1024.7; p = 0. 044). None of the scores obtained in the VAS significantly changed after surgery. After surgery, there were significant correlations of VAS scores and GLP-1 levels in question 01 ("how hungry do you feel?"; R = -0.928; p = .008) and GLP-2 levels in questions 02 ("how full do you feel?" R = 0.943; p = 0.005) and 04 ("how much do you think you can eat now? R = -0.829; p = 0.042).
CONCLUSIONS: Modified BPD does not lead to significant changes in satiety evaluated by the VAS; different aspects of satiety regulation are correlated with the postprandial levels of GLP-1 (hunger feeling) and GLP-2 (satiation feeling and desire to eat) 1 year after modified BPD, signaling a specific postoperative gut hormone-related modulation of appetite.

Entities:  

Keywords:  Bariatric surgery; Biliopancreatic diversion; Glucagon-like peptide 1; Glucagon-like peptide 2; Satiety response

Mesh:

Substances:

Year:  2018        PMID: 28808865     DOI: 10.1007/s11695-017-2875-3

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  48 in total

Review 1.  Pharmacology, physiology, and mechanisms of incretin hormone action.

Authors:  Jonathan E Campbell; Daniel J Drucker
Journal:  Cell Metab       Date:  2013-05-16       Impact factor: 27.287

2.  Long-term changes in gut hormones, appetite and food intake 1 year after subtotal gastrectomy with normal body weight.

Authors:  T Y Jeon; S Lee; H H Kim; Y J Kim; J G Lee; D W Jeong; Y J Kim
Journal:  Eur J Clin Nutr       Date:  2010-05-19       Impact factor: 4.016

3.  GLP-1 and GLP-2 Levels are Correlated with Satiety Regulation After Roux-en-Y Gastric Bypass: Results of an Exploratory Prospective Study.

Authors:  Everton Cazzo; José Carlos Pareja; Elinton Adami Chaim; Bruno Geloneze; Maria Rita Lazzarini Barreto; Daniéla Oliveira Magro
Journal:  Obes Surg       Date:  2017-03       Impact factor: 4.129

Review 4.  The validity of appetite ratings.

Authors:  C de Graaf
Journal:  Appetite       Date:  1993-10       Impact factor: 3.868

5.  Prediction of Diabetes Remission at Long Term Following Biliopancreatic Diversion.

Authors:  Nicola Scopinaro; Gian Franco Adami; Paolo Bruzzi; Renzo Cordera
Journal:  Obes Surg       Date:  2017-07       Impact factor: 4.129

6.  Biliopancreatic diversion.

Authors:  N Scopinaro; G F Adami; G M Marinari; E Gianetta; E Traverso; D Friedman; G Camerini; G Baschieri; A Simonelli
Journal:  World J Surg       Date:  1998-09       Impact factor: 3.352

7.  Binge eating following biliopancreatic diversion for obesity.

Authors:  G F Adami; P Gandolfo; F H Cocchi; B Bauer; A R Petti; N Scopinaro
Journal:  Appetite       Date:  1995-10       Impact factor: 3.868

8.  The Diabetes Surgery Summit II Guidelines: a Disease-Based Clinical Recommendation.

Authors:  Ricardo V Cohen; Scott Shikora; Tarissa Petry; Pedro Paulo Caravatto; Carel W Le Roux
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

9.  Long-term outcomes after biliopancreatic diversion with and without duodenal switch: 2-, 5-, and 10-year data.

Authors:  Monica Sethi; Edward Chau; Allison Youn; Yan Jiang; George Fielding; Christine Ren-Fielding
Journal:  Surg Obes Relat Dis       Date:  2016-03-09       Impact factor: 4.734

10.  Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations.

Authors:  Francesco Rubino; David M Nathan; Robert H Eckel; Philip R Schauer; K George M M Alberti; Paul Z Zimmet; Stefano Del Prato; Linong Ji; Shaukat M Sadikot; William H Herman; Stephanie A Amiel; Lee M Kaplan; Gaspar Taroncher-Oldenburg; David E Cummings
Journal:  Diabetes Care       Date:  2016-06       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.